Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mensa

Showing results (711-720 of 792) with videos related to

Pageof 80
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 30, 2019
Safety and Pharmacokinetics of Glecaprevir/Pibrentasvir in Adults With Chronic Genotype 1-6 Hepatitis C Virus Infections and Compensated Liver DiseaseEdward Gane, Fred Poordad, Neddie Zadeikis, et al.
Journal of Medical Virology|March 10, 2025
COVID-19 Patients Benefitting From Remdesivir for Improved Survival: A Neural Network-Based ApproachCarolina Garcia-Vidal, Christian Teijón-Lumbreras, Tommaso Francesco Aiello, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|June 9, 2026
Real-World Experience with Cefiderocol in Hematologic Patients with MalignanciesAna Martinez-Urrea, Laura Mezzogori, Antonio Gallardo-Pizarro, et al.
Journal of Chemotherapy (Florence, Italy)|November 6, 2003
Clinical characteristics and response to newer quinolones in Legionella pneumonia: a report of 28 casesJ Santos, L Aguilar, E García-Méndez, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 9, 2016
Brief Report: Late-Onset Cryopyrin-Associated Periodic Syndrome Due to Myeloid-Restricted Somatic NLRP3 MosaicismAnna Mensa-Vilaro, María Teresa Bosque, Giuliana Magri, et al.
Antimicrobial Agents and Chemotherapy|December 17, 2014
Efficacy and safety of faldaprevir, deleobuvir, and ribavirin in treatment-naive patients with chronic hepatitis C virus infection and advanced liver fibrosis or cirrhosisStefan Zeuzem, Vicente Soriano, Tarik Asselah, et al.
Scientific Reports|March 1, 2026
Spatial and temporal variability of supraglacial algae on an Alpine glacier (Forni Glacier, Italy)Flavia Dory, Roberto Ambrosini, Anees Ahmad, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 7, 2025
Rectal colonization by multidrug-resistant Gram-negative bacteria and subsequent bacteraemia in haematological patientsAntonio Gallardo-Pizarro, Carlos Lopera, Olivier Peyrony, et al.
Antiviral Therapy|April 6, 2013
Faldaprevir (BI 201335), deleobuvir (BI 207127) and ribavirin oral therapy for treatment-naive HCV genotype 1: SOUND-C1 final resultsStefan Zeuzem, Tarik Asselah, Peter Angus, et al.
Journal of Hepatology|March 20, 2018
High SVR12 with 8-week and 12-week glecaprevir/pibrentasvir therapy: An integrated analysis of HCV genotype 1-6 patients without cirrhosisMassimo Puoti, Graham R Foster, Stanley Wang, et al.
Pageof 80

Showing results (711-720 of 792) with videos related to

Sort By:
Pageof 80
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 30, 2019
Safety and Pharmacokinetics of Glecaprevir/Pibrentasvir in Adults With Chronic Genotype 1-6 Hepatitis C Virus Infections and Compensated Liver DiseaseEdward Gane, Fred Poordad, Neddie Zadeikis, et al.
Journal of Medical Virology|March 10, 2025
COVID-19 Patients Benefitting From Remdesivir for Improved Survival: A Neural Network-Based ApproachCarolina Garcia-Vidal, Christian Teijón-Lumbreras, Tommaso Francesco Aiello, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|June 9, 2026
Real-World Experience with Cefiderocol in Hematologic Patients with MalignanciesAna Martinez-Urrea, Laura Mezzogori, Antonio Gallardo-Pizarro, et al.
Journal of Chemotherapy (Florence, Italy)|November 6, 2003
Clinical characteristics and response to newer quinolones in Legionella pneumonia: a report of 28 casesJ Santos, L Aguilar, E García-Méndez, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 9, 2016
Brief Report: Late-Onset Cryopyrin-Associated Periodic Syndrome Due to Myeloid-Restricted Somatic NLRP3 MosaicismAnna Mensa-Vilaro, María Teresa Bosque, Giuliana Magri, et al.
Antimicrobial Agents and Chemotherapy|December 17, 2014
Efficacy and safety of faldaprevir, deleobuvir, and ribavirin in treatment-naive patients with chronic hepatitis C virus infection and advanced liver fibrosis or cirrhosisStefan Zeuzem, Vicente Soriano, Tarik Asselah, et al.
Scientific Reports|March 1, 2026
Spatial and temporal variability of supraglacial algae on an Alpine glacier (Forni Glacier, Italy)Flavia Dory, Roberto Ambrosini, Anees Ahmad, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 7, 2025
Rectal colonization by multidrug-resistant Gram-negative bacteria and subsequent bacteraemia in haematological patientsAntonio Gallardo-Pizarro, Carlos Lopera, Olivier Peyrony, et al.
Antiviral Therapy|April 6, 2013
Faldaprevir (BI 201335), deleobuvir (BI 207127) and ribavirin oral therapy for treatment-naive HCV genotype 1: SOUND-C1 final resultsStefan Zeuzem, Tarik Asselah, Peter Angus, et al.
Journal of Hepatology|March 20, 2018
High SVR12 with 8-week and 12-week glecaprevir/pibrentasvir therapy: An integrated analysis of HCV genotype 1-6 patients without cirrhosisMassimo Puoti, Graham R Foster, Stanley Wang, et al.
Pageof 80